Alcami to Acquire Contract Packaging Organization Tjoapack

Alcami Corporation, a prominent U.S.-based contract development and manufacturing organization (CDMO), has announced a definitive agreement to acquire Tjoapack, a global contract packaging organization, for an undisclosed amount. This strategic transaction, expected to close in the second quarter of 2026, aims to enhance Alcami's global CDMO platform and expand its operational footprint in Europe.

Founded in 1989, Tjoapack has established itself as a trusted provider of contract primary and secondary packaging solutions, boasting over 35 years of experience in the pharmaceutical and biotechnology sectors. The company operates facilities in Clinton, Tennessee, and Etten-Leur, The Netherlands, equipped with 23 packaging lines and a workforce of over 400 skilled personnel. Tjoapack serves more than 40 commercial markets worldwide, offering a diverse range of services including oral solid dose packaging, sterile injectables, and kitting.

The acquisition is strategically significant for Alcami as it marks the company's first expansion into the European market. By integrating Tjoapack's capabilities, Alcami aims to create a more robust end-to-end global CDMO platform that offers U.S.-Europe supply chain redundancy. This development is particularly beneficial for pharmaceutical and biotech companies seeking to streamline their operations and reduce supply chain complexities. The addition of Tjoapack’s Qualified Person (QP) release services will further enhance Alcami’s offerings, allowing clients to manage their global distribution from a single supplier.

The transaction is poised to provide Tjoapack's clients with access to Alcami's comprehensive suite of services, which includes pharmaceutical testing labs, sterile and oral solid dose drug product manufacturing, and GMP-compliant pharma storage. This integration is expected to facilitate smoother delivery of medicines globally while minimizing the number of supplier hand-offs, thereby improving overall efficiency for clients in the highly regulated pharmaceutical landscape.

The acquisition reflects broader trends in the pharmaceutical sector, where companies are increasingly seeking to consolidate operations and enhance service offerings through strategic partnerships. As the demand for integrated solutions continues to rise, this transaction positions Alcami and Tjoapack to better serve their clients' evolving needs in a competitive marketplace. The successful integration of Tjoapack into Alcami’s operations could serve as a model for future M&A activity within the CDMO sector, highlighting the importance of geographic expansion and service diversification in driving growth.